Is nitrofurantoin (Macrobid) appropriate for a penicillin‑allergic patient with a lower urinary tract infection caused by Group B Streptococcus?

Nitrofurantoin (Macrobid) is NOT appropriate for treating Group B Streptococcus urinary tract infections in penicillin-allergic patients

Nitrofurantoin should not be used for GBS UTIs because it lacks adequate activity against this organism and is specifically indicated only for E. coli and S. saprophyticus. 1

Why Nitrofurantoin Fails for GBS

FDA-Approved Indications Are Restrictive

• Macrobid is FDA-approved only for acute uncomplicated cystitis caused by susceptible strains of Escherichia coli or Staphylococcus saprophyticus 1
• The FDA label explicitly states that nitrofurantoin "lacks the broader tissue distribution of other therapeutic agents" and warns that "many patients who are treated with Macrobid are predisposed to persistence or reappearance of bacteriuria" 1
• Group B Streptococcus is not listed among approved pathogens 1

Limited In Vitro Data Shows Inadequate Coverage

• While one small study (n=52) found all GBS isolates technically "sensitive" to nitrofurantoin, 2% still showed intermediate sensitivity, and the study specifically recommended nitrofurantoin only for GBS bacteriuria, not as primary treatment 2
• The IDSA guidelines for uncomplicated cystitis list nitrofurantoin as first-line therapy but only for infections caused by typical uropathogens (E. coli, S. saprophyticus), with clinical cure rates of 88-93% for these organisms 3

Appropriate Alternatives for Penicillin-Allergic Patients with GBS UTI

Assess Allergy Severity First

For patients WITHOUT high-risk allergy history (no anaphylaxis, angioedema, respiratory distress, or urticaria):

• Use cefazolin as the preferred alternative 4
• Cefazolin achieves effective concentrations and has proven efficacy against GBS 4

For patients WITH high-risk allergy history:

• Obtain susceptibility testing for clindamycin and erythromycin on the GBS isolate 4
• If susceptible to both: use clindamycin 900 mg IV every 8 hours 4
• If resistant or susceptibility unknown: use vancomycin 1 g IV every 12 hours 4

Critical Pitfall to Avoid

Do not assume nitrofurantoin is adequate simply because it concentrates in urine. The FDA explicitly warns that nitrofurantoin's lack of tissue distribution leads to treatment failures, and the drug should be reserved only for its approved indications 1. When GBS bacteriuria persists or recurs after nitrofurantoin, "other therapeutic agents with broader tissue distribution should be selected" 1.

Clinical Decision Algorithm

1. Confirm GBS as causative pathogen via urine culture 1
2. Document penicillin allergy type and severity 4
3. If low-risk allergy → cefazolin 4
4. If high-risk allergy → obtain GBS susceptibility testing 4
5. If susceptible to clindamycin/erythromycin → clindamycin 4
6. If resistant or unknown → vancomycin 4

Never use nitrofurantoin as empiric or definitive therapy for GBS UTI, regardless of allergy status. 1, 2